{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:29:18Z","timestamp":1781087358964,"version":"3.54.1"},"reference-count":86,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5761\/atcs.ra.15-00187","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T22:03:04Z","timestamp":1441663384000},"page":"418-427","source":"Crossref","is-referenced-by-count":28,"title":["Multidisciplinary Treatment Approach for Prosthetic Vascular Graft Infection in the Thoracic Aortic Area"],"prefix":"10.5761","volume":"21","author":[{"given":"Takeshiro","family":"Fujii","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, School of Medicine, Toho University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, School of Medicine, Toho University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Coselli JS, Crawford ES, Williams TW, et al. Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg 1990; 50: 868-81.","DOI":"10.1016\/0003-4975(90)91111-N"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Darouiche RO. Treatment of infections associated with surgical implants. N Engl Med 2004; 350: 1422-9.","DOI":"10.1056\/NEJMra035415"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Akowuah E, Narayan P, Angelini G, et al. Management of prosthetic graft infection after surgery of the thoracic aorta: removal of the prosthetic graft is not necessary. J Thorac Cardiovasc Surg 2007; 134: 1051-2.","DOI":"10.1016\/j.jtcvs.2007.02.055"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Coselli JS, K\u00f6ksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999; 67: 1990-3; discussion 1997-8.","DOI":"10.1016\/S0003-4975(99)00355-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Cernohorsky P, Reijnen MM, Tielliu IF, et al. The relevance of aortic endograft prosthetic infection. J Vasc Surg 2011; 54: 327-33.","DOI":"10.1016\/j.jvs.2010.12.067"},{"key":"6","unstructured":"6) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infetion Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250-78."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346: 1871-7.","DOI":"10.1056\/NEJMoa003069"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253: 1082-93.","DOI":"10.1097\/SLA.0b013e31821175f8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tossios P, Karatzopoulos A, Tsagakis K, et al. Treatment of infected thoracic aortic prosthetic grafts with the in situ preservation strategy: a review of its history, surgical technique, and results. Heart Lung Circ 2014; 23: 24-31.","DOI":"10.1016\/j.hlc.2013.09.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Czerny M, von Allmen R, Opfermann P, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg 2011; 92: 1657-62.","DOI":"10.1016\/j.athoracsur.2011.06.073"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nakajima N, Masuda M, Ichinose M, et al. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg 1999; 67: 1994-6; discussion 1997-8.","DOI":"10.1016\/S0003-4975(99)00358-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Teebken OE, Bisdas T, Assadian O, et al. Recommendations for reporting treatment of aortic graft infections. Eur J Vasc Endovasc Surg 2012; 43: 174-81.","DOI":"10.1016\/j.ejvs.2011.11.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shiono N, Fujii T, Kawasaki M, et al. Frequency of detection of oral pathogenic bacteria in patients undergoing surgery for infectious endocarditis: is blood exposed to oral bacteria on a daily basis? J Clin Exp Cardiolog 2013; 4: 7","DOI":"10.4172\/2155-9880.1000254"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sasaki Y. The in vitro research of bacterial invasion of prosthetic vascular grafts: comparison of elastomer-sealed and gelatin-coated Dacron vascular grafts. Surg Today 2014; 44: 1542-7.","DOI":"10.1007\/s00595-013-0761-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Low RN, Wall SD, Jeffrey RB, et al. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology 1990; 175: 157-62.","DOI":"10.1148\/radiology.175.1.2315475"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Qvarfordt PG, Reilly LM, Mark AS, et al. Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg 1985; 150: 227-31.","DOI":"10.1016\/0002-9610(85)90125-4"},{"key":"17","unstructured":"17) Williamson MR, Boyd CM, Shah HR. Prosthetic vascular graft infections: diagnosis and treatment. Crit Rev Diagn Imaging 1989; 29: 181-213."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Dennis JW, Littooy FN, Greisler HP, et al. Anastomotic pseudoaneurysms. A continuing late complication of vascular reconstructive procedures. Arch Surg 1986; 121: 314-7.","DOI":"10.1001\/archsurg.1986.01400030068012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Orton DF, LeVeen RF, Saigh JA, et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics 2000; 20; 977-93.","DOI":"10.1148\/radiographics.20.4.g00jl12977"},{"key":"20","unstructured":"20) Williamson MR, Boyd CM, Shah HR. Prosthetic graft infections: diagnosis and treatment. Crit Rev Diagn Imaging 1989; 29: 181-213."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Bruggink JL, Glaudemans AW, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010; 40: 348-54.","DOI":"10.1016\/j.ejvs.2010.05.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005; 42: 919-25.","DOI":"10.1016\/j.jvs.2005.07.038"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: the role of 18F-FDG PET\/CT. J Nucl Med 2007; 48: 1230-6.","DOI":"10.2967\/jnumed.107.040253"},{"key":"24","unstructured":"24) Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging 2009; 53: 35-40."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tokuda Y, Oshima H, Araki Y, et al. Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography\/computed tomography. Eur J Cardiothorac Surg 2013; 43: 1183-7.","DOI":"10.1093\/ejcts\/ezs693"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Keidar Z, Pirmisashvili N, Leiderman M, et al. 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med 2014; 55: 392-5.","DOI":"10.2967\/jnumed.113.128173"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Erba PA, Leo G, Sollini M, et al. Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. Eur J Nucl Med Mol Imaging 2014; 41: 357-68.","DOI":"10.1007\/s00259-013-2582-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Lawrence PF, Dries DJ, Alazraki N, et al. Indium 111-labeled leukocyte scanning for detection of prosthetic vascular graft infection. J Vasc Surg 1985; 2: 165-73.","DOI":"10.1016\/0741-5214(85)90186-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Teebken OE, Bisdas T, Assadian O, et al. Recommendations for reporting treatment of aortic graft infections. Eur J Vasc Endovasc Surg 2012; 43: 174-81.","DOI":"10.1016\/j.ejvs.2011.11.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg 2008; 21: 119-23.","DOI":"10.1053\/j.semvascsurg.2008.05.008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Cramton SE, Gerke C, Schnell NF, et al. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67: 5427-33.","DOI":"10.1128\/IAI.67.10.5427-5433.1999"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996; 20: 1083-91.","DOI":"10.1111\/j.1365-2958.1996.tb02548.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hayes PD, Nasim A, London NJ, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999; 30: 92-8.","DOI":"10.1016\/S0741-5214(99)70180-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Wilson SE. New alternatives in management of the infected vascular prosthesis. Surg Infect (Larchmt) 2001; 2: 175-7.","DOI":"10.1089\/109629601750469492"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Clin Infect Dis 2004; 38: 1128-30.","DOI":"10.1086\/383060"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Langerhuus SN, T\u00f8nnesen EK, Jensen KH, et al. Brief report: biomarkers of aortic vascular prosthetic graft infection in a porcine model with Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2010; 29: 1453-6.","DOI":"10.1007\/s10096-010-1008-x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.","DOI":"10.1016\/0140-6736(93)90277-N"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011; 17: 764-9.","DOI":"10.1007\/s10156-011-0254-x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005; 11: 234-8.","DOI":"10.1007\/s10156-005-0400-4"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Saleem BR, Meerwaldt R, Tielliu IF, et al. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 2010; 200: 47-52.","DOI":"10.1016\/j.amjsurg.2009.05.018"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Roy D, Grove DI. Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. J Infect 2000; 40: 184-7.","DOI":"10.1016\/S0163-4453(00)80014-6"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Baddour LM; Infectious Diseases Society of America\u2019s Emerging Infections Network. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001; 322: 209-12.","DOI":"10.1097\/00000441-200110000-00011"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Legout L, Delia P, Sarraz-Bournet B, et al. Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. BMC Infect Dis 2014; 14: 228.","DOI":"10.1186\/1471-2334-14-228"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Jeanmonod P, Laschke MW, Gola N, et al. Early host tissue response to different types of vascular prosthesis coated with silver acetate or vaporized metallic silver. Eur J Endovasc Surg 2014; 47: 680-8.","DOI":"10.1016\/j.ejvs.2014.03.006"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) French BG, Chard RB, Sholler GF, et al. Salvage of infected truncus repair using rifampicin-impregnated gelatin-sealed graft. Ann Thorac Surg 1994; 57: 754-5.","DOI":"10.1016\/0003-4975(94)90587-8"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 1994; 19: 675-82.","DOI":"10.1016\/S0741-5214(94)70041-9"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Iida Y, Ito T, Kitahara H, et al. In-situ reconstruction with a rifampicin-bonded gelatin-sealed woven Dacron graft for prosthetic graft infection with pseudoaneurysms after ascending aortic replacement for type A aortic dissection. Ann Vasc Dis 2014; 1: 68-71","DOI":"10.3400\/avd.cr.13-00083"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Vicaretti M, Hawthorne WJ, Ao PY, et al. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg 1998; 6: 268-73.","DOI":"10.1016\/S0967-2109(98)00003-9"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Gao H, Sandermann J, Prag J, et al. Rifampicin-soaked silver polyester versus expanded polytetrafluoro-ethylene grafts for in situ replacement of infected grafts in a porcine randomised controlled trial. Eur J Vasc Endovasc Surg 2012; 43: 582-7.","DOI":"10.1016\/j.ejvs.2012.02.011"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Sato S, Saiki Y, Nitta Y, et al. Redo total aortic arch replacement using an extended homograft for graft infection. Jpn J Thorac Cardiovasc Surg 2006; 54: 448-50. (in Japanese with English abstract)","DOI":"10.1007\/s11748-006-0029-y"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Fujiwara H, Saiki Y, Nitta Y, et al. Surgical treatment of a retrosternal pseudoaneurysm arising from the posterior aortic root. Jpn J Thorac Cardiovasc Surg 2005; 53: 615-8. (in Japanese with English abstract)","DOI":"10.1007\/s11748-005-0150-3"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Vogt PR. Arterial allografts in treating aortic graft infections: something old, something new. Semin Vasc Surg 2011; 24: 227-33.","DOI":"10.1053\/j.semvascsurg.2011.10.008"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg 2007; 134: 839-43.","DOI":"10.1016\/j.jtcvs.2007.05.059"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) LeMaire SA, DiBardino DJ, K\u00f6ksoy C, et al. Proximal aortic reoperations in patients with composite valve grafts. Ann Thorac Surg 2002; 74: S1777-80; discussion S1792-9.","DOI":"10.1016\/S0003-4975(02)04152-8"},{"key":"55","unstructured":"55) Fujii T, Watanabe Y, Shiono N, et al. An aortic root pseudoaneurysm that developed after implantation of a rectus abdominis muscle flap to treat an MRSA mediastinitis: a case report. Ann Thorac Cardiovasc Surg 2010; 16: 63-6."},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg 1984; 37: 72-7.","DOI":"10.1016\/S0003-4975(10)60714-X"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Zhang QX, Magovern CJ, Mack CA, et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res 1997; 67: 147-54.","DOI":"10.1006\/jsre.1996.4983"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Taguchi S, Mori A, Suzuki R, et al. Technique for using pedicled latissimus dorsi muscle flaps to wrap prosthetic grafts in an infected thoracic aorta. Ann Vasc Surg 2013; 27: 1223-7.","DOI":"10.1016\/j.avsg.2013.04.009"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Takano T, Terasaki T, Wada Y, et al. Treatment of prosthetic graft infection after thoracic aorta replacement. Ann Thorac Cardiovasc Surg 2014; 20: 304-9.","DOI":"10.5761\/atcs.oa.13-00059"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Yamashiro S, Arakaki R, Kise Y, et al. Potential role of omental wrapping to prevent infection after treatment for infectious thoracic aortic aneurysms. Eur J Cardiothorac Surg 2013; 43: 1177-82.","DOI":"10.1093\/ejcts\/ezs600"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Obdeijn MC, de Lange MY, Lichtendahl DH, et al. Vacuum-assisted closure in the treatment of poststernotomy mediastinitis. Ann Thorac Surg 1999; 68: 2358-60.","DOI":"10.1016\/S0003-4975(99)01159-5"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Fuchs U, Zittermann A, Stuettgen B, et al. Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared to conventional therapy with open packing: a retrospective analysis. Ann Thorac Surg 2005; 79: 526-31.","DOI":"10.1016\/j.athoracsur.2004.08.032"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Domkowski PW, Smith ML, Gonyon DL, et al. Evaluation of vacuum-assisted closure in the treatment of poststernotomy mediastinitis. J Thorac Cardiovasc Surg 2003; 126: 386-90.","DOI":"10.1016\/S0022-5223(03)00352-0"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Saiki Y, Kawamoto S, Sai S, et al. An effective vacuum-assisted closure treatment for mediastinitis with aortic arch replacement. Interact Cardiovasc Thorac Surg 2008; 7: 712-4.","DOI":"10.1510\/icvts.2008.176727"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Yasuura K, Okamoto H, Morita S, et al. Results of omental flap transposition for deep sternal wound infection after cardiovascular surgery. Ann Surg 1998; 227: 455-9.","DOI":"10.1097\/00000658-199803000-00019"},{"key":"66","unstructured":"66) Uchida T, Uchino H, Kuroda Y, et al. Omental turnover technique; an alternative of omental transfer for sternal wound infection after cardiac surgery. Jpn J Thorac Surg 2012; 65: 546-9. (in Japanese with English abstract)"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Gustafsson R, Johnsson P, Algotsson L, et al. Vacuum-assisted closure therapy guided by C-reactive protein level in patients with deep sternal wound infection. J Thorac Cardiovasc Surg 2002; 123: 895-900.","DOI":"10.1067\/mtc.2002.121306"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Czerny M, von Allmen R, Opfermann P, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg 2011; 92: 1657-62.","DOI":"10.1016\/j.athoracsur.2011.06.073"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Rahman IA, Angelini GD, Hamilton M, et al. Pericardial neo-aorta to bridge long segment defects after infected aortic reconstructions. J Card Surg 2013; 28: 295-7.","DOI":"10.1111\/jocs.12077"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Tamura K, Yoshitaka H, Totsugawa T, et al. Bridge use of endovascular repair and delayed open operation for infected aneurysm of aortic arch. Ann Thorac Surg 2013; 96: 1471-3.","DOI":"10.1016\/j.athoracsur.2013.01.095"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Calligaro KD, Veith FJ, Yuan JG, et al. Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J Vasc Surg 2003; 38: 1199-205.","DOI":"10.1016\/S0741-5214(03)01043-7"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Saji M, Taguchi S, Uchiyama K, et al. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995; 31: 225-8.","DOI":"10.1016\/0195-6701(95)90070-5"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Javerliat I, Go\u00ebau-Brissonni\u00e8re O, Bruneval P, et al. Experimental study of a new vascular graft prebonded with antibiotic: healing, toxicity, and antibiotic retention. Ann Vasc Surg 2007; 21: 603-10.","DOI":"10.1016\/j.avsg.2007.06.005"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Giacometti A, Cirioni O, Ghiselli R, et al. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. Antimicrob Agents Chemother 2000; 44: 3306-9.","DOI":"10.1128\/AAC.44.12.3306-3309.2000"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Huh J, Chen JC, Furman GM, et al. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. J Surg Res 1998; 74: 54-8.","DOI":"10.1006\/jsre.1997.5188"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Yasim A, Gul M, Atahan E, et al. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Eur J Vasc Endovasc Surg 2006; 31: 274-9.","DOI":"10.1016\/j.ejvs.2005.09.018"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Stone PA, Armstrong PA, Bandyk DF, et al. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. J Vasc Surg 2006; 44: 757-61.","DOI":"10.1016\/j.jvs.2006.05.056"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Hodgkiss-Harlow KD, Bandyk DF. Antibiotic therapy of aortic graft infection: treatment and prevention recommendations. Semin Vasc Surg 2011; 24: 191-8.","DOI":"10.1053\/j.semvascsurg.2011.10.013"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Stone PA, Mousa AY, Hass SM, et al. Antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary vascular surgical site infections. J Vasc Surg 2012; 55: 1706-11.","DOI":"10.1016\/j.jvs.2011.12.037"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Healy AH, Reid BB, Allred BD, et al. Antibiotic-impregnated beads for the treatment of aortic graft infection. Ann Thorac Surg 2012; 93: 984-5.","DOI":"10.1016\/j.athoracsur.2011.07.066"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Sato S, Nitta Y, Saiki Y, et al. Enhanced perigraft angiogenesis prevents prosthetic graft infection. Ann Thorac Surg 2008; 86: 1278-84.","DOI":"10.1016\/j.athoracsur.2008.03.035"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis 2002; 15: 395-400.","DOI":"10.1097\/00001432-200208000-00007"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Neuhauser MM, Weinstein RA, Rydman R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289: 885-8.","DOI":"10.1001\/jama.289.7.885"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.","DOI":"10.1086\/510393"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Drew RH. Antimicrobial stewardship programs: how to start and steer a successful program. J Manag Care Pharm 2009; 15(2 Suppl): S18-23.","DOI":"10.18553\/jmcp.2009.15.s2.18"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Evans RS, Pestotnik SL, Classen DC, et al. Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother 1999; 33: 1026-31.","DOI":"10.1345\/aph.18391"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/5\/21_ra.15-00187\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T02:49:12Z","timestamp":1599533352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/21\/5\/21_ra.15-00187\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.ra.15-00187","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}